Publisher: Wiley-Blackwell

Related content
Volume 167, Number 5, 1 November 2012

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

How cutaneous eruptions help to understand the mode of action of kinase inhibitors
pp. 965-967(3)
Authors: Dummer, R.; Tsao, H.; Robert, C.

Favourites:Add to Favourites

‘Is it safe?’ Safety is a process, not a question
pp. 968-969(2)
Author: Shear, N.H.

Favourites:Add to Favourites
Favourites:Add to Favourites

Concepts in psoriasis: psoriasis and the extracellular matrix
pp. 980-986(7)
Authors: McFadden, J.; Fry, L.; Powles, A.V.; Kimber, I.

Favourites:Add to Favourites

Evidence‐based treatments for female pattern hair loss: a summary of a Cochrane systematic review
pp. 995-1010(16)
Authors: van Zuuren, E.J.; Fedorowicz, Z.; Carter, B.

Favourites:Add to Favourites

Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination
pp. 1011-1016(6)
Authors: Fernández, S.; España, A.; Navedo, M.; Barona, L.

Favourites:Add to Favourites

Clinical significance of Koebner phenomenon in vitiligo
pp. 1017-1024(8)
Authors: van Geel, N.; Speeckaert, R.; De Wolf, J.; Bracke, S.; Chevolet, I.; Brochez, L.; Lambert, J.

Favourites:Add to Favourites

An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial
pp. 1025-1031(7)
Authors: Bostoen, J.; Bracke, S.; De Keyser, S.; Lambert, J.

Favourites:Add to Favourites

Laypersons’ sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs
pp. 1037-1041(5)
Authors: Luttrell, M.J.; McClenahan, P.; Hofmann‐Wellenhof, R.; Fink‐Puches, R.; Soyer, H.P.

Favourites:Add to Favourites

Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy
pp. 1042-1047(6)
Authors: Sattler, E.C.; Maier, T.; Hoffmann, V.S.; Hegyi, J.; Ruzicka, T.; Berking, C.

Favourites:Add to Favourites
Favourites:Add to Favourites

Site‐specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates
pp. 1053-1066(14)
Authors: Bagabir, R.; Byers, R.J.; Chaudhry, I.H.; Müller, W.; Paus, R.; Bayat, A.

Favourites:Add to Favourites

Analysis of 303 Ro/SS‐A antibody‐positive patients: is this antibody a possible marker for malignancy?
pp. 1067-1075(9)
Authors: Böckle, B.C.; Stanarevic, G.; Ratzinger, G.; Sepp, N.T.

Favourites:Add to Favourites

Keratolysis exfoliativa (dyshidrosis lamellosa sicca): a distinct peeling entity
pp. 1076-1084(9)
Authors: Chang, Y.Y.; van der Velden, J.; van der Wier, G.; Kramer, D.; Diercks, G.F.H.; van Geel, M.; Coenraads, P.J.; Zeeuwen, P.L.J.M.; Jonkman, M.F.

Favourites:Add to Favourites

Effectiveness of combined pulsed dye and Q‐switched ruby laser treatment for large to giant congenital melanocytic naevi
pp. 1085-1091(7)
Authors: Funayama, E.; Sasaki, S.; Furukawa, H.; Hayashi, T.; Yamao, T.; Takahashi, K.; Yamamoto, Y.; Oyama, A.

Favourites:Add to Favourites

Direct primary closure without undermining in the repair of vermilionectomy defects of the lower lip
pp. 1092-1097(6)
Authors: Barry, R.B.M.; McKenzie, J.; Berg, D.; Langtry, J.A.A.

Favourites:Add to Favourites

Constitutive activation of c‐Abl/protein kinase C‐δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma
pp. 1098-1105(8)
Authors: Noda, S.; Asano, Y.; Akamata, K.; Aozasa, N.; Taniguchi, T.; Takahashi, T.; Ichimura, Y.; Toyama, T.; Sumida, H.; Yanaba, K.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S.

Favourites:Add to Favourites

Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma
pp. 1106-1110(5)
Authors: Yeh, I.; McCalmont, T.H.; LeBoit, P.E.

Favourites:Add to Favourites

Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort
pp. 1111-1117(7)
Authors: della Torre, R.; Combescure, C.; Cortés, B.; Marazza, G.; Beltraminelli, H.; Naldi, L.; Borradori, L.

Favourites:Add to Favourites

Primary cutaneous B‐cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO‐EORTC classification
pp. 1118-1123(6)
Authors: Bessell, E.M.; Humber, C.E.; O’Connor, S.; English, J.S.E.; Perkins, W.; Dickinson, P.D.; Patel, A.N.

Favourites:Add to Favourites

Melanoma incidence and mortality in Europe: new estimates, persistent disparities
pp. 1124-1130(7)
Authors: Forsea, A.M.; del Marmol, V.; de Vries, E.; Bailey, E.E.; Geller, A.C.

Favourites:Add to Favourites

Are accelerometers a useful tool for measuring disease activity in children with eczema? Validity, responsiveness to change, and acceptability of use in a clinical trial setting
pp. 1131-1137(7)
Authors: Wootton, C.I.; Koller, K.; Lawton, S.; O’Leary, C.; Thomas, K.S.; on behalf of the SWET study teamcr6

Favourites:Add to Favourites

Imatinib mesylate in scleroderma‐associated diffuse skin fibrosis: a phase II multicentre randomized double‐blinded controlled trial
pp. 1138-1144(7)
Authors: Prey, S.; Ezzedine, K.; Doussau, A.; Grandoulier, A.‐S.; Barcat, D.; Chatelus, E.; Diot, E.; Durant, C.; Hachulla, E.; de Korwin‐Krokowski, J.‐D.; Kostrzewa, E.; Quemeneur, T.; Paul, C.; Schaeverbeke, T.; Seneschal, J.; Solanilla, A.; Sparsa, A.; Bouchet, S.; Lepreux, S.; Mahon, F.‐X.; Chene, G.; Taïeb, A.

Favourites:Add to Favourites

The safety of ustekinumab treatment in patients with moderate‐to‐severe psoriasis and latent tuberculosis infection
pp. 1145-1152(8)
Authors: Tsai, T.‐F.; Ho, V.; Song, M.; Szapary, P.; Kato, T.; Wasfi, Y.; Li, S.; Shen, Y.K.; Leonardi, C.; on behalf of the PHOENIX 1, PHOENIX 2, ACCEPT, PEARLcr10; Japanese Ustekinumab Study Groupscr11

Favourites:Add to Favourites

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
pp. 1153-1160(8)
Authors: Anforth, R.M.; Blumetti, T.C.M.P.; Kefford, R.F.; Sharma, R.; Scolyer, R.A.; Kossard, S.; Long, G.V.; Fernandez‐Peñas, P.

Favourites:Add to Favourites

Human papillomavirus type 56‐associated Bowen disease
pp. 1161-1164(4)
Authors: Shimizu, A.; Tamura, A.; Abe, M.; Amano, H.; Motegi, S.; Nakatani, Y.; Hoshino, H; Ishikawa, O.

Favourites:Add to Favourites

Usefulness of a global clinical ichthyosis vulgaris scoring system for predicting common FLG null mutations in an adult caucasian population
pp. 1165-1169(5)
Authors: Ezzedine, K.; Droitcourt, C.; Ged, C.; Diallo, A.; Hubiche, T.; de Verneuil, H.; Boralevi, F.; Taïeb, A.

Favourites:Add to Favourites

Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis
pp. 1170-1174(5)
Authors: Irla, N.; Navarini, A.A.; Yawalkar, N.

Favourites:Add to Favourites

A long‐term study of a patient with anti‐p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading
pp. 1179-1183(5)
Authors: Monshi, B.; Groth, S.; Richter, L.; Schmidt, E.; Zillikens, D.; Rappersberger, K.

Favourites:Add to Favourites

Cutaneous amalgam tattoo in a dental professional: an unreported occupational argyria
pp. 1184-1185(2)
Authors: Rumayor Piña, A.; Martínez Martínez, M.; Toral Rizo, V.H.; Ajudarte Lopes, M.; Paes de Almeida, O.

Favourites:Add to Favourites
Favourites:Add to Favourites

Pustular psoriasis precipitated by cytomegalovirus infection
pp. 1186-1189(4)
Authors: Yoneda, K.; Matsuoka‐Shirahige, Y.; Demitsu, T.; Kubota, Y.

Favourites:Add to Favourites

Treatment of eosinophilic pustulosis of infancy with topical tacrolimus
pp. 1189-1191(3)
Authors: Patel, N.P.; Laguda, B.; Roberts, N.M.; Francis, N.D.; Agnew, K.

Favourites:Add to Favourites

Traction: risk factor or coincidence in central centrifugal cicatricial alopecia?
pp. 1191-1193(3)
Authors: Khumalo, N.P.; Gumedze, F.

Favourites:Add to Favourites

News and Notices
pp. 1194-1195(2)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more